Swedish pharmaceutical and digital therapeutic company Orexo has launched its digital solution for alcohol use disorder, vorvida, through the help of Accenture’s INTIENT Patient platform.
The INTIENT Patient platform, which is powered by Google Cloud, supports vorvida’s virtual cognitive behavioral therapy services by providing secure data storage and artificial intelligence-enabled analytics.
"...
Swedish pharma company Orexo is jumping into the American digital-therapeutics game with the announcement of two new products, deprexis for treating depression symptoms and vorvida, a treatment for problematic alcohol use.
The new treatments are coming to the US market thanks to relaxed FDA regulations surrounding digital health products for psychiatric disorders, which was enacted as a result...
